Companies / Celldex Therapeutics, Inc. / Activity
Activity — Celldex Therapeutics, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Palo Alto Investors LP 13F manager | New | Common stock | $9.40M | +296K | 296,408 0.38% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $2.70M | +85K | 85,026 0.11% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common stock | $626.8K | +17K | 16,846 0.02% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $330.0K | +10K | 10,403 0.01% of shares | low |
| Q1 2026 as of | Amundi 13F manager | New | Common stock | $296.6K | +9K | 9,351 0.01% of shares | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | New | Common stock | $246.7K | +8K | 7,777 <0.01% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | New | Common stock | $206.5K | +6K | 5,550 <0.01% of shares | low |
| Q2 2026 as of | Meeder Asset Management Inc 13F manager | New | Common stock | $186.4K | +5K | 5,009 <0.01% of shares | low |
| Q4 2021 as of | Leonteq Securities AG 13F manager | New | Common stock | $19.3K | +500 | 500 <0.01% of shares | low |
| Q1 2026 as of | Assetmark, Inc 13F manager | New | Common stock | $666 | +21 | 21 <0.01% of shares | low |
| Q1 2026 as of | MassMutual Private Wealth & Trust, FSB 13F manager | New | Common stock | $571 | +18 | 18 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $254 | +8 | 8 <0.01% of shares | low |